Visus Therapeutics

Patent cliffs & loss of exclusivity

Presbyopia-correcting eye drops

Company

Company Operating StatusAcquired
Crunchbase URLhttps://www.crunchbase.com/organization/visus-therapeutics
Facebook URLhttps://www.facebook.com/visustx/
Instagram URLhttps://www.instagram.com/visustx/
LinkedIn URLhttps://www.linkedin.com/company/visus-therapeutics
Pitchbook URLhttps://pitchbook.com/profiles/company/437818-87
Seedtable URLhttps://seedtable.com/companies/visus-therapeutics
Twitter URLhttps://twitter.com/visustx

1 upcoming patent cliff

DrugIngredientTypeCliff
  1. YUVEZZIBRIMONIDINE TARTRATE; CARBACHOLSmall mol.Nov 2042

Loss-of-exclusivity dates are derived from the FDA Orange & Purple Books; company detail is from the CliffBio graph. Estimates are projections, not legal advice.